HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Westchester County Prohibits “Conspicuous” Ephedra Store Displays

This article was originally published in The Tan Sheet

Executive Summary

Ephedra products may not be displayed prominently in retail stores in Westchester County, N.Y., under a measure that takes effect Oct. 28

You may also be interested in...



Chattem Exiting Ephedra Market With Dexatrim Reformulations

Chattem is getting out of the ephedra business and is set to ship three reformulated Dexatrim SKUs by the end of September

CRN Ephedra Study Could Help NYC Council Take "Balanced" Approach

A study of ephedra's safety contracted by the Council for Responsible Nutrition could provide the New York City Council with information necessary to take a "balanced and scientific approach" toward regulating the dietary supplement ingredient, the trade association maintains.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131153

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel